SDS-PAGE
VEGFR2 / Flk-1 / CD309 / KDR recombinant protein
Recombinant Rat VEGFR2 / Flk-1 / CD309 / KDR Protein (His tag)
Purity
> 90 % as determined by SDS-PAGE
Synonyms
VEGFR2 / Flk-1 / CD309 / KDR; Recombinant Rat VEGFR2 / Flk-1 / CD309 / KDR Protein (His tag); Vegfr-2; VEGFR2 / Flk-1 / CD309 / KDR recombinant protein
Host
Human Cells
Purity/Purification
> 90 % as determined by SDS-PAGE
Form/Format
Lyophilized from sterile PBS, pH 7.4
Sequence Length
467
Application Notes
The recombinant rat KDR comprises 752 amino acids and predicts a molecular mass of 84.3 kDa. The apparent molecular mass of the rat KDR is approximately 120-130 kDa in SDS-PAGE under reducing conditions due to glycosylation.
Predicted N Terminal
Ala 20
Endotoxin
< 1.0 EU per mug of the protein as determined by the LAL method
Preparation and Storage
Samples are stable for up to twelve months from date of receipt at -70 degree C
SDS-PAGE
SDS-PAGE
Related Product Information for VEGFR2 / Flk-1 / CD309 / KDR recombinant protein
Background: VEGFR2, also called as KDR or Flk-1, is identified as the receptor for VEGF and VEGFC and an early marker for endothelial cell progenitors, whose expression is restricted to endothelial cells in vivo. VEGFR2 was shown to be the primary signal transducer for angiogenesis and the development of pathological conditions such as cancer and diabetic retinopathy. It has been shown that VEGFR2 is expressed mainly in the endothelial cells, and the expression is upregulated in the tumor vasculature. Thus the inhibition of VEGFR2 activity and its downstream signaling are important targets for the treatment of diseases involving angiogenesis. VEGFR2 transduces the major signals for angiogenesis via its strong tyrosine kinase activity. However, unlike other representative tyrosine kinase receptors, VEGFR2 does not use the Ras pathway as a major downstream signaling but rather uses the phospholipase C-protein kinase C pathway to signal mitogen-activated protein (MAP)-kinase activation and DNA synthesis. VEGFR2 is a direct and major signal transducer for pathological angiogenesis, including cancer and diabetic retinopathy, in cooperation with many other signaling partners; thus, VEGFR2 and its downstream signaling appear to be critical targets for the suppression of these diseases. VEGF and VEGFR2-mediated survival signaling is critical to endothelial cell survival, maintenance of the vasculature and alveolar structure and regeneration of lung tissue. Reduced VEGF and VEGFR2 expression in emphysematous lungs has been linked to increased endothelial cell death and vascular regression.
Description: A DNA sequence encoding the rat KDR (EDM04022.1) extracellular domain (Met 1-Glu 760) was expressed, fused with a polyhistidine tag at the C-terminus.
Description: A DNA sequence encoding the rat KDR (EDM04022.1) extracellular domain (Met 1-Glu 760) was expressed, fused with a polyhistidine tag at the C-terminus.
NCBI and Uniprot Product Information
NCBI GI #
NCBI GeneID
Molecular Weight
52,059 Da
NCBI Official Full Name
interleukin 9 receptor, isoform CRA_a
NCBI Official Synonym Full Names
interleukin 9 receptor
NCBI Official Symbol
Il9r
NCBI Protein Information
interleukin-9 receptor
UniProt Protein Name
Interleukin 9 receptor, isoform CRA_a
UniProt Gene Name
Il9r
NCBI Description
a cytokine receptor for IL9 [RGD, Feb 2006]
Similar Products
Product Notes
The VEGFR2 / Flk-1 / CD309 / KDR il9r (Catalog #AAA2547251) is a Recombinant Protein produced from Human Cells and is intended for research purposes only. The product is available for immediate purchase. The recombinant rat KDR comprises 752 amino acids and predicts a molecular mass of 84.3 kDa. The apparent molecular mass of the rat KDR is approximately 120-130 kDa in SDS-PAGE under reducing conditions due to glycosylation. Researchers should empirically determine the suitability of the VEGFR2 / Flk-1 / CD309 / KDR il9r for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "VEGFR2 / Flk-1 / CD309 / KDR, Recombinant Protein" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
